This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Discussing Abbott Laboratories two new over-the-counter continuous glucose monitoring (CGM) systems – The Lingo and Libre Rio

Ticker(s): ABT, SENS, DXCM, MDT

Who's the expert?

Institution: Columbia University

  • Associate Professor of Endocrinology at Columbia University.
  • Manages 800 patients with diabetes and 280 patients who are on insulin pumps.
  • Research focuses on the role of developmental pathways in the regulation of Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease and the use of existing therapeutic agents in other scientific areas in novel applications to ameliorate obesity-induced complications including cancer. 

Interview Questions
Q1.

Please describe your background and patient setting

Added By: ben_admin
Q2.

How many patients do you manage who utilize a CGM device?

Added By: ben_admin
Q3.

What are the most popular CGM devices used today?

Added By: ben_admin
Q4.

What is your opinion of an over-the-counter CGM?

Added By: ben_admin
Q5.

What patient is most likely to want an over-the-counter CGM?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.